insights_auto
Why is OCUL down 4,95%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
5,57 US$
arrow_downward
-4,95%(-0,29) 1D
5,60 US$
arrow_upward
+0,54% (+0,030)bedtimeAfter hours
Closed: 20 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
5,76 US$
High
5,95 US$
Low
5,54 US$
Mkt. cap
1,23 მლრდ.
Avg. vol.
2,99 მლნ.
Volume
2,90 მლნ.
52-wk high
16,44 US$
52-wk low
5,54 US$
EPS
-1,46 US$
Beta
1,22
Shares outstanding
220,02 მლნ.
No. of employees
325
Open
5,76 US$
High
5,95 US$
Low
5,54 US$
Mkt. cap
1,23 მლრდ.
Avg. vol.
2,99 მლნ.
Volume
2,90 მლნ.
52-wk high
16,44 US$
52-wk low
5,54 US$
EPS
-1,46 US$
Beta
1,22
Shares outstanding
220,02 მლნ.
No. of employees
325
News stories
From web sources and news partners
Yahoo! Finance Canada
·
17 საათის წინ
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com